SOPHiA GENETICS (SOPH)
(Delayed Data from NSDQ)
$3.53 USD
-0.17 (-4.59%)
Updated Nov 15, 2024 03:59 PM ET
After-Market: $3.60 +0.07 (1.98%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth C Momentum D VGM
SOPHiA GENETICS SA (SOPH) Price Targets
| Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
|---|---|---|---|
| $6.00 | $7.00 | $5.00 | 62.16% |
Find the top stocks with the greatest target price potential and Zacks Rank of 1 or 2
Price Target
Based on short-term price targets offered by four analysts, the average price target for SOPHiA GENETICS SA comes to $6.00. The forecasts range from a low of $5.00 to a high of $7.00. The average price target represents an increase of 62.16% from the last closing price of $3.70.
Analyst Price Targets (4 )
Broker Rating
SOPHiA GENETICS SA currently has an average brokerage recommendation (ABR) of 1.60 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by five brokerage firms. The current ABR compares to an ABR of 1.60 a month ago based on five recommendations.
Of the five recommendations deriving the current ABR, three are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 60% and 20% of all recommendations. A month ago, Strong Buy made up 60%, while Buy represented 20%.
Broker Rating Breakdown
Brokerage Recommendations
| Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| ABR | 1.60 | 1.60 | 1.60 | 1.60 | 1.60 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
| Date | Brokerage Firm | Analyst | Previous | Current |
|---|---|---|---|---|
| 10/16/2024 | Cowen & Co. | Daniel Brennan | Strong Buy | Strong Buy |
| 9/24/2024 | BTIG | Mark Massaro | Strong Buy | Strong Buy |
| 8/7/2024 | Not Identified | Not Identified | Moderate Buy | Moderate Buy |
| 6/27/2024 | Guggenheim Securities | Subbu Nambi | Not Available | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
| Current ABR | 1.60 |
| ABR (Last week) | 1.60 |
| # of Recs in ABR | 5 |
| Average Target Price | $6.00 |
| LT Growth Rate | NA |
| Industry | Medical Info Systems |
| Industry Rank by ABR | 43 of 252 |
| Current Quarter EPS Est: | -0.27 |
SOPH FAQs
SOPHiA GENETICS SA (SOPH) currently has an average brokerage recommendation (ABR) of 1.60 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 5 brokerage firms.
The average price target for SOPHiA GENETICS SA (SOPH) is $6.00. The current on short-term price targets is based on 1 reports.
The forecasts for SOPHiA GENETICS SA (SOPH) range from a low of $5 to a high of $7. The average price target represents a increase of $62.16 from the last closing price of $3.70.
The current UPSIDE for SOPHiA GENETICS SA (SOPH) is 62.16%
Based on short-term price targets offered by four analysts, the average price target for SOPHiA GENETICS SA comes to $6.00. The forecasts range from a low of $5.00 to a high of $7.00. The average price target represents an increase of 62.16% from the last closing price of $3.70.